欧美文化:Omicron subvariant infections on rise in U.S., coinciding with allergy season

LOS ANGELES, March 23 (Xinhua) -- The BA.2 sub-lineage of the Omicron variant has made up over one third of new COVID-19 infections in the United States, coinciding with the allergy season that may complicate symptoms and delay timely distinction.

The BA.2 variant accounted for about 34.9 percent of new COVID-19 infections in the country in the week ending March 19, according to the latest data of the U.S. Centers for Disease Control and Prevention (CDC).

This data went up from 22.3 percent a week prior, and 15.8 percent two weeks before.

The BA.2 variant is steadily gaining its ground in the country, with infections almost doubling each week in February, the data showed.

In the northeastern part of the country, BA.2's prevalence has surpassed 50 percent in the latest week.

With COVID-19 cases rising in parts of Europe and Asia due to BA.2's rapid spread, scientists worry that the variant may soon push cases up in the United States.

Anthony Fauci, the nation's top infectious disease expert, said he expects "an uptick in cases" due to BA.2, but not necessarily a massive surge like other variants have caused.

Fauci said the new strain is about 50 to 60 percent more transmissible than the first Omicron strain, adding that it could take over as the dominant strain in the United States.

Adding to the complication is the start of allergy season. Experts are concerned about allergy season because some early symptoms of COVID-19 resemble allergies -- runny or stuffy nose, or a cough and fatigue.

It may cause delay in distinguishing between the coronavirus and pollen allergies.

Meanwhile, experts cautioned the decline in COVID-19 case counts from peak high in early January may not reveal the full picture of the pandemic.

Keri Althoff, a researcher at Johns Hopkins Bloomberg School of Public Health, said that CDC case counts may underestimate the true numbers because some people are no longer getting tested, and some others are testing at home and not reporting the results.

Also, not every specimen is genetically sequenced to determine the variant, she said.

Health officials and experts stressed COVID-19 vaccines and boosters remain the best ways to prevent serious illness from the virus.